Healthcare Industry News: iZon Lens
News Release - May 8, 2006
Ophthonix Receives 11th Patent
Invention Enables Correction of Aberrations in Any Optical System, Including Telescopes, Binoculars, Cameras or Microscopes, as Well as EyeglassesSAN DIEGO--(HSMN NewsFeed)--May 8, 2006--Ophthonix, a company producing High Definition vision technology that provides consumers with superior optical clarity and crispness compared to any other available vision correction, announced it has received an 11th patent. This broad-ranging patent covers a dramatically different approach to correcting aberrations across virtually any optical system -- including the recently introduced iZon Wavefront-Guided Eyeglasses.
Conventional efforts to reducing aberrations in an optical system rely on polishing and grinding of the lens. These processes are limited because they are unable to effectively address all aberrations in a simultaneous fashion. Rather, they focus on one aberration at a time. So, while an aberration such as coma is being eliminated, another, such as spherical aberration, may be increased. "Conventional manufacturing methods are too ineffective and inefficient to fully address the complexity and sophistication of the broad range of optical products in the market," said Andreas Dreher, Ph.D., CEO and president of Ophthonix. By exposing its proprietary material, iZonik(TM), to a controlled light source, Ophthonix is able to address all aberrations of any optical system in a very unique manner. "We first used this new technology to correct the complex pattern of aberrations in a patient's optical fingerprint, or iPrint(TM), to provide them with the benefits of High Definition vision from the fully customized iZon Wavefront-Guided Eyeglasses," added Dreher.
This patent has very broad reach. The covered technology may be particularly useful in correcting static aberrations in just about any optical imaging system, such as telescopes or even cameras. "Just as we have brought High Definition vision to consumers with the iZon Lenses, we can bring High Definition imaging to those who use telescopes or microscopes, or even cameras used in photography," noted Dreher. Additionally, the technology may be employed to correct aberrations in laser beams or associated optics in detection or even communication instruments. "There is no limit to the application in any optical system, the sky's the limit," concluded Dreher.
With the introduction of the iZon Single Vision lens in April 2005 and the iZon Progressives in March 2006, Ophthonix has transformed the very nature of the ophthalmic industry. Follow-up marketing research among patients who have purchased iZon Lenses indicates very high levels of satisfaction across a variety of activities, as well as lens preference over their previous brand. Additionally, the iZon Lens was recently evaluated in an FDA-validated night driving simulator, where it was shown to provide a significant cushion of safety for consumers -- a 25-foot improvement in reaction at 55 mph, or 20 percent reduction in the National Highway Transportation Agency measure of perception-reaction when driving at night.
Eye Care Practitioners should contact Ophthonix for availability of the Z-View Aberrometer and iZon Lens in their area.
About Ophthonix
Ophthonix Inc., a San Diego-based, venture-funded ophthalmic company, is developing exceptional vision assessment and correction technologies to greatly enhance visual acuity. Ophthonix is currently advancing a system that will improve the ability of optometrists and ophthalmologists to care for their patients and benefit the millions around the world requiring vision correction. Ophthonix is located at 10455 Pacific Center Court, San Diego, CA 92121, www.ophthonix.com, media@ophthonix.com, 858-869-2086.
Source: Ophthonix
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
